• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对伊朗普通人群的全国性调查,旨在估算 EQ-5D-5L 的效价值。

A national survey of Iranian general population to estimate a value set for the EQ-5D-5L.

机构信息

Department of Health Management, Policy, and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

出版信息

Qual Life Res. 2023 Jul;32(7):2079-2087. doi: 10.1007/s11136-023-03378-1. Epub 2023 Mar 10.

DOI:10.1007/s11136-023-03378-1
PMID:36897530
Abstract

OBJECTIVES

The main aim of this study is to estimate a national value set of the EQ-5D-5L questionnaire for Iran.

METHODS

The composite time trade-off (cTTO) and discrete choice experiment (DCE) methods; and the protocol for EuroQol Portable Valuation Technology (EQ-PVT) were used to estimate the Iran national value set. 1179 face-to-face computer-assisted interviews were conducted with adults that were recruited from five Iran major cities in 2021. Generalized least squares, Tobit, heteroskedastic, logit, and hybrid models were used to analyze the data and to identify the best fitting model.

RESULTS

According to the logical consistency of the parameters, significance levels and prediction accuracy indices of the MAE; a heteroscedastic censored Tobit hybrid model combining cTTO and DCE responses was considered as the best fitting model to estimate the final value set. The predicted values ranged from - 1.19 for the worst health state (55555) to 1 for full health (11111), with 53.6% of the predicted values being negative. Mobility was the most influential dimension on health state preference values.

CONCLUSIONS

The present study estimated a national EQ-5D-5L value set for Iranian policy makers and researchers. The value set enables the EQ-5D-5L questionnaire to use to calculate QALYs to assist the priority setting and efficient allocation of limited healthcare resources.

摘要

目的

本研究的主要目的是估算伊朗 EQ-5D-5L 问卷的国家价值体系。

方法

采用复合时间权衡法(cTTO)和离散选择实验(DCE)方法;以及 EuroQol 便携式估值技术(EQ-PVT)协议来估算伊朗国家价值体系。2021 年,在伊朗五个主要城市,对 1179 名成年人进行了面对面的计算机辅助访谈。使用广义最小二乘法、Tobit、异方差、Logit 和混合模型来分析数据并确定最佳拟合模型。

结果

根据参数的逻辑一致性、MAE 的显著水平和预测精度指标;一种将 cTTO 和 DCE 反应相结合的异方差截尾 Tobit 混合模型被认为是估计最终价值体系的最佳拟合模型。预测值范围从最差健康状态(55555)的-1.19 到完全健康(11111)的 1,其中 53.6%的预测值为负值。移动性是对健康状态偏好值影响最大的维度。

结论

本研究为伊朗政策制定者和研究人员估算了国家 EQ-5D-5L 价值体系。该价值体系使 EQ-5D-5L 问卷能够用于计算 QALY,以协助确定优先事项和有效分配有限的医疗保健资源。

相似文献

1
A national survey of Iranian general population to estimate a value set for the EQ-5D-5L.一项针对伊朗普通人群的全国性调查,旨在估算 EQ-5D-5L 的效价值。
Qual Life Res. 2023 Jul;32(7):2079-2087. doi: 10.1007/s11136-023-03378-1. Epub 2023 Mar 10.
2
Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study.沙特阿拉伯王国 EQ-5D-5L 的评估:一项全国代表性研究。
Value Health. 2024 May;27(5):552-561. doi: 10.1016/j.jval.2024.01.017. Epub 2024 Feb 9.
3
A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.一种用于获取健康状态偏好的混合建模方法:葡萄牙 EQ-5D-5L 值集。
Qual Life Res. 2019 Dec;28(12):3163-3175. doi: 10.1007/s11136-019-02226-5. Epub 2019 Jun 14.
4
The EQ-5D-5L Valuation Study in Egypt.埃及 EQ-5D-5L 估值研究。
Pharmacoeconomics. 2022 Apr;40(4):433-447. doi: 10.1007/s40273-021-01100-y. Epub 2021 Nov 17.
5
An EQ-5D-5L Value Set for Ghana Using an Adapted EuroQol Valuation Technology Protocol.使用经改编的欧洲生活质量评估技术协议制定的加纳EQ-5D-5L价值集。
Value Health Reg Issues. 2025 Jan;45:101045. doi: 10.1016/j.vhri.2024.101045. Epub 2024 Sep 4.
6
Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.基于DCE和/或TTO数据的价值集比较:日本EQ-5D-5L健康状态评分
Value Health. 2016 Jul-Aug;19(5):648-54. doi: 10.1016/j.jval.2016.03.1834. Epub 2016 Apr 26.
7
Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments.秘鲁的 EQ-5D-5L 评估:时间权衡和离散选择实验的直接比较。
Value Health. 2020 Jul;23(7):880-888. doi: 10.1016/j.jval.2020.05.004. Epub 2020 Jul 18.
8
Dutch Tariff for the Five-Level Version of EQ-5D.EQ-5D五级版本的荷兰关税。
Value Health. 2016 Jun;19(4):343-52. doi: 10.1016/j.jval.2016.01.003. Epub 2016 Mar 30.
9
Valuing Health State: An EQ-5D-5L Value Set for Ethiopians.重视健康状况:埃塞俄比亚人的 EQ-5D-5L 值集。
Value Health Reg Issues. 2020 Sep;22:7-14. doi: 10.1016/j.vhri.2019.08.475. Epub 2019 Nov 2.
10
The EQ-5D-5L valuation study for Trinidad and Tobago.特立尼达和多巴哥的 EQ-5D-5L 估值研究。
Health Qual Life Outcomes. 2024 Jul 2;22(1):51. doi: 10.1186/s12955-024-02266-7.

引用本文的文献

1
Beyond illness: how chronic conditions and unhealthy behaviors impact health-related quality of life among Iranian women.超越疾病:慢性病和不健康行为如何影响伊朗女性的健康相关生活质量
BMC Public Health. 2025 Jul 30;25(1):2591. doi: 10.1186/s12889-025-23977-6.
2
Linking health-related quality of life to labor supply: a study of nurses in Western Iran.将健康相关生活质量与劳动力供给联系起来:伊朗西部护士的一项研究。
BMC Nurs. 2025 May 29;24(1):613. doi: 10.1186/s12912-025-03284-6.
3
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.

本文引用的文献

1
Determination of a cost-effectiveness threshold for cancer interventions in Iran.伊朗癌症干预措施成本效益阈值的确定。
Front Oncol. 2022 Dec 12;12:1039589. doi: 10.3389/fonc.2022.1039589. eCollection 2022.
2
The EQ-5D-5L Valuation Study in Egypt.埃及 EQ-5D-5L 估值研究。
Pharmacoeconomics. 2022 Apr;40(4):433-447. doi: 10.1007/s40273-021-01100-y. Epub 2021 Nov 17.
3
Utility Values in Colorectal Cancer Patients Treated with Chemotherapy.化疗治疗的结直肠癌患者的效用值。
健康经济学中离散选择实验的发展态势:一项系统综述
Pharmacoeconomics. 2025 May 21. doi: 10.1007/s40273-025-01495-y.
4
The Use of EQ-5D in the Middle East and North Africa Region: A Systematic Literature Review.EQ-5D在中东和北非地区的应用:一项系统文献综述
Pharmacoeconomics. 2025 May 10. doi: 10.1007/s40273-025-01483-2.
5
Population norms of health-related quality of life in Iran: findings from a national EQ-5D-5L study.伊朗健康相关生活质量的人群规范:一项全国性EQ-5D-5L研究的结果
Health Qual Life Outcomes. 2025 May 7;23(1):48. doi: 10.1186/s12955-025-02378-8.
6
Quality-adjusted life expectancy norms for the Iranian population.伊朗人口的质量调整生命预期规范。
Popul Health Metr. 2025 Feb 13;23(1):5. doi: 10.1186/s12963-025-00366-0.
7
EQ-5D-5L value set for Norway: a hybrid model using cTTO and DCE data.挪威的EQ-5D-5L价值集:一种使用条件价值法和离散选择实验数据的混合模型。
Qual Life Res. 2025 Feb;34(2):417-427. doi: 10.1007/s11136-024-03837-3. Epub 2024 Nov 20.
8
Valuation of the EQ-5D-3L in Jordan.约旦EQ-5D-3L量表的估值
Eur J Health Econ. 2025 Apr;26(3):487-501. doi: 10.1007/s10198-024-01712-z. Epub 2024 Sep 3.
9
Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration.使用具有持续时间的离散选择实验来评估伊朗首都的 SF-6Dv2。
Qual Life Res. 2024 Jul;33(7):1853-1863. doi: 10.1007/s11136-024-03649-5. Epub 2024 Apr 17.
10
Peritoneal dialysis vs. hemodialysis among patients with end-stage renal disease in Iran: which is more cost-effective?伊朗终末期肾病患者中腹膜透析与血液透析的比较:哪种更具成本效益?
BMC Nephrol. 2024 Mar 6;25(1):85. doi: 10.1186/s12882-024-03530-0.
Cancer Invest. 2022 Jan;40(1):46-54. doi: 10.1080/07357907.2021.1992632. Epub 2021 Oct 26.
4
Health-related quality of life and its associated factors in patients with type 2 diabetes mellitus.2型糖尿病患者的健康相关生活质量及其相关因素
SAGE Open Med. 2020 Oct 26;8:2050312120965314. doi: 10.1177/2050312120965314. eCollection 2020.
5
Estimating Utility Values for Health States of DFU Patients Using EQ-5D-5L and cTTO.利用 EQ-5D-5L 和 cTTO 估算糖尿病足溃疡患者健康状态的效用值。
Int J Low Extrem Wounds. 2022 Mar;21(1):41-49. doi: 10.1177/15347346211014392. Epub 2021 May 3.
6
Assessment of Utility in Migraine: Mapping the Migraine-Specific Questionnaire to the EQ-5D-5L.偏头痛效用评估:偏头痛专用问卷与 EQ-5D-5L 的映射。
Value Health Reg Issues. 2021 Sep;25:57-63. doi: 10.1016/j.vhri.2020.12.003. Epub 2021 Mar 25.
7
The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data.丹麦 EQ-5D-5L 值集:使用 cTTO 和 DCE 数据的混合模型。
Appl Health Econ Health Policy. 2021 Jul;19(4):579-591. doi: 10.1007/s40258-021-00639-3. Epub 2021 Feb 2.
8
Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country.在发展中国家的结直肠癌和乳腺癌患者中,将 QLQ-C30 映射到 EQ-5D-5L 和 SF-6D-V2。
Value Health Reg Issues. 2021 May;24:57-66. doi: 10.1016/j.vhri.2020.06.006. Epub 2021 Jan 25.
9
Interim value set for the EQ-5D-5L in Iran using the Crosswalk method.采用交叉法为伊朗的EQ-5D-5L设定的临时值集。
Med J Islam Repub Iran. 2020 Sep 15;34:121. doi: 10.34171/mjiri.34.121. eCollection 2020.
10
Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.哪些多属性效用仪器推荐用于成本效用分析?国家卫生技术评估(HTA)指南的回顾。
Eur J Health Econ. 2020 Nov;21(8):1245-1257. doi: 10.1007/s10198-020-01195-8. Epub 2020 Jun 8.